| RS1946487230 |
CDKN1B
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS1946487548 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS1946488462 |
CDKN1B
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 4, Multiple endocrine neoplasia type 4 |
| RS1946491613 |
CDKN1B
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 4, Multiple endocrine neoplasia type 4 |
| RS1946491661 |
CDKN1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, CDKN1B-related disorder |
| RS1946492962 |
CDKN1B
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 4, Multiple endocrine neoplasia type 4 |
| RS1946493725 |
CDKN1B
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS1946496773 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 4, Ovarian cancer |
| RS1946497104 |
CDKN1B
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 4, Multiple endocrine neoplasia type 4 |
| RS1946498276 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia type 4 |
| RS1946498768 |
CDKN1B
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS1946499901 |
MRE11
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast carcinoma, Ataxia-telangiectasia-like disorder 1 |
| RS1946508324 |
DPAGT1
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation, Congenital disorder of glycosylation |
| RS1946512581 |
DPAGT1
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation, Congenital disorder of glycosylation |
| RS1946513256 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia type 4 |
| RS1946523602 |
TECTA
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21 |
| RS1946583076 |
GP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Bernard Soulier syndrome, Bernard Soulier syndrome |
| RS1946586230 |
GP9
|
Health Risk |
Likely pathogenic |
Bernard Soulier syndrome, Bernard Soulier syndrome |
| RS1946597477 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1946605498 |
TECTA
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 21, Autosomal recessive nonsyndromic hearing loss 21 |
| RS1946656233 |
DDX11
|
Health Risk |
Pathogenic |
Warsaw breakage syndrome, Warsaw breakage syndrome |
| RS1946660318 |
TECTA
|
Health Risk |
Pathogenic |
— |
| RS1946669738 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS1946676671 |
MRE11
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia-like disorder, Ataxia-telangiectasia-like disorder |
| RS1946724126 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS1946727506 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS1946778092 |
CPT1A
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase 1A deficiency, Carnitine palmitoyl transferase 1A deficiency |
| RS1946780929 |
CPT1A
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase 1A deficiency, Carnitine palmitoyl transferase 1A deficiency |
| RS1946792293 |
DDX11
|
Health Risk |
Likely pathogenic |
Warsaw breakage syndrome, Warsaw breakage syndrome |
| RS1946857788 |
MRE11
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia-like disorder, Ataxia-telangiectasia-like disorder |
| RS1946956410 |
ABCC9
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS1947001391 |
GUCY2C
|
Health Risk |
Pathogenic |
— |
| RS1947002584 |
GUCY2C
|
Health Risk |
Pathogenic |
Congenital diarrhea 6, Congenital diarrhea 6 |
| RS1947056659 |
TECTA
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 12, Autosomal dominant nonsyndromic hearing loss 12 |
| RS1947057220 |
TECTA
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 12, Autosomal dominant nonsyndromic hearing loss 12 |
| RS1947102571 |
MPDZ
|
Health Risk |
Pathogenic |
— |
| RS1947104738 |
MPDZ
|
Health Risk |
Pathogenic |
— |
| RS1947157785 |
ETV6
|
Health Risk |
Likely pathogenic |
— |
| RS1947184803 |
HEPACAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Megalencephalic leukoencephalopathy with subcortical cysts 2A, Megalencephalic leukoencephalopathy with subcortical cysts 2B |
| RS1947244829 |
POMT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Walker-Warburg congenital muscular dystrophy |
| RS1947265336 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia-like disorder, Hereditary cancer-predisposing syndrome |
| RS1947274911 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS1947296046 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS1947324005 |
AQP2
|
Health Risk |
Pathogenic |
— |
| RS1947324508 |
AQP2
|
Health Risk |
Pathogenic |
— |
| RS1947335024 |
SBF2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4B2 |
| RS1947349400 |
AQP2
|
Health Risk |
Pathogenic |
— |
| RS1947358808 |
KCNA1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Episodic ataxia type 1 |
| RS1947361964 |
AQP2
|
Health Risk |
Likely pathogenic |
— |
| RS1947362334 |
AQP2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS1947522752 |
POMT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1947531929 |
NECAP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 21 |
| RS1947971579 |
SC5D
|
Health Risk |
Pathogenic |
Lathosterolosis, Lathosterolosis |
| RS1948089932 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1948102480 |
RACGAP1
|
Health Risk |
Pathogenic |
Anemia, congenital dyserythropoietic |
| RS1948104184 |
POMT1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Walker-Warburg congenital muscular dystrophy |
| RS1948107534 |
POMT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1948141206 |
CEACAM16
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1948142385 |
CD3E
|
Health Risk |
Pathogenic |
Immunodeficiency 18, Immunodeficiency 18 |
| RS1948212796 |
FOLR1
|
Health Risk |
Pathogenic |
— |
| RS1948231142 |
FOLR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral folate transport deficiency, Cerebral folate transport deficiency |
| RS1948252170 |
CASP8
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS1948278092 |
EHMT1
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1948326461 |
CHD4
|
Health Risk |
Pathogenic/Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS1948326612 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS1948327010 |
CHD4
|
Health Risk |
Pathogenic/Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS1948331954 |
SCNN1A
|
Health Risk |
Pathogenic |
Pseudohypoaldosteronism, type IB1 |
| RS1948335884 |
CD3G
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to CD3gamma deficiency, Combined immunodeficiency due to CD3gamma deficiency |
| RS1948336129 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS1948388503 |
CD3G
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to CD3gamma deficiency, Combined immunodeficiency due to CD3gamma deficiency |
| RS1948391148 |
CD3G
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency disease, Severe combined immunodeficiency disease |
| RS1948408994 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1948418139 |
CD3G
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency disease, Severe combined immunodeficiency disease |
| RS1948418309 |
CHD4
|
Health Risk |
Pathogenic |
— |
| RS1948434432 |
CHD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS1948436363 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS1948453702 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS1948478259 |
FGD4
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1948507281 |
GUCY2C
|
Health Risk |
Likely pathogenic |
— |
| RS1948507892 |
IQCB1
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 5, Senior-Loken syndrome 5 |
| RS1948513922 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1948519774 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1948522736 |
RB1
|
Health Risk |
Likely pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1948522792 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1948522929 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1948523741 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1948532502 |
CHD4
|
Health Risk |
Likely pathogenic |
Moyamoya angiopathy with developmental delay, Moyamoya angiopathy with developmental delay |
| RS1948533760 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1948533963 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS1948534023 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1948534047 |
RB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinoblastoma, Hereditary retinoblastoma |
| RS1948534542 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1948565964 |
CAPN1
|
Health Risk |
Pathogenic |
Autosomal recessive spastic paraplegia type 76, Autosomal recessive spastic paraplegia type 76 |
| RS1948569124 |
GRIN2B
|
Health Risk |
Likely pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1948581537 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS1948582304 |
CAPN1
|
Health Risk |
Pathogenic |
— |
| RS1948582433 |
CAPN1
|
Health Risk |
Pathogenic |
— |
| RS1948582497 |
CAPN1
|
Health Risk |
Pathogenic |
— |
| RS1948588956 |
SCNN1A
|
Health Risk |
Pathogenic |
— |
| RS1948590484 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |